Hughes C S, Shen J W, Subjeck J R
Division of Radiation Biology, Roswell Park Memorial Institute, Buffalo, New York 14263.
Cancer Res. 1989 Aug 15;49(16):4452-4.
The induction of glucose-regulated proteins by a variety of specific inducers leads to an increase in resistance to Adriamycin (Shen et al., Proc. Natl., Acad. Sci. USA, 84: 3278, 1987). In this study we examine several additional agents for cross-resistance induced during a glucose-regulated response in an attempt to better define the mechanism through which this phenomenon occurs. When anoxia, calcium ionophore A23187, or 2-deoxyglucose are used, a substantial resistance is obtained against the topoisomerase II-targeted agent, etoposide. Partial resistance is induced against vincristine and actinomycin D. Glucose-regulated protein inducers do not substantially alter cellular response to either bleomycin or radiation. In the case of mitomycin C there is a cellular sensitization with anoxia and 2-deoxyglucose while calcium ionophore A23187 had no effect on survival. This study suggests that the resistance obtained during a glucose-regulated response against etoposide and Adriamycin may involve topoisomerase II.
多种特定诱导剂诱导葡萄糖调节蛋白会导致对阿霉素的抗性增加(Shen等人,《美国国家科学院院刊》,84: 3278, 1987)。在本研究中,我们检测了几种其他药物,以研究在葡萄糖调节反应过程中诱导产生的交叉抗性,试图更好地确定这一现象发生的机制。当使用缺氧、钙离子载体A23187或2-脱氧葡萄糖时,对拓扑异构酶II靶向药物依托泊苷产生了显著抗性。对长春新碱和放线菌素D诱导产生了部分抗性。葡萄糖调节蛋白诱导剂不会显著改变细胞对博来霉素或辐射的反应。对于丝裂霉素C,缺氧和2-脱氧葡萄糖会使细胞致敏,而钙离子载体A23187对细胞存活没有影响。这项研究表明,在葡萄糖调节反应过程中对依托泊苷和阿霉素产生的抗性可能涉及拓扑异构酶II。